Products
API
APIs Offered | |||
S.No | Name | CAS No | Therapeutic Area |
1 | Tramadol Hydrochloride (EP/BP/USP/IP) | 27203—92-5 | Acute Pain |
2 | Cetirizine Di Hydrochloride ( EP/USP/IP) | 83881-52-1 | Anti-Histamine |
3 | Amlodipine Besylate (EP/BP/IP) | 111470-99-6 | Anti–Hypertensive |
4 | Telmisartan (EP/IP) | 144701-48-4 | |
5 | Irbesartan (EP/USP) | 138402-11-6 | |
6 | Olmesartan Medoxomil (IN HOUSE SPEC) | 144689-63-4 | |
7 | Lacidipine (BP) | 103890-78-4 | |
8 | Levetiracetam (USP/EP) | 102767-28-2 | Anti Convulsant |
9 | Sildenafil Citrate (IP/IHS) | 139755-83-2 | Anti- Erectile Dysfunction |
10 | Montelukast Sodium (USP/IP/IN HOUSE SPEC) | 151767-02-1 | Anti-Asthmatic |
11 | Fenofibrate (EP) | 49562-28-9 | Anti-Cholesterol |
12 | Racecadotril (EP/USP) | 81110-73-8 | Anti-Diarrhoeal |
13 | Sumatriptan Succinate (USP/EP) | 103628-48-4 | Anti-Migraine |
14 | Tamsulosin Hydrochloride (EP/USP) | 106463-17-6 | Anti-Benign Prostatic Hyperplasia |
APIs –Under Scale Up | |||
S.No | Name | CAS No | Therapeutic Area |
15 | Losartan Potassium (USP/EP) | 114798-26-4 | Anti-Hypertensive |
16 | Valsartan (USP/EP) | 137862-53-4 | |
17 | Candesartan Cilexetil (IN HOUSE SPEC) | 139481-59-7 | |
18 | Dextromethorphan HBr (USP/EP) | 6700-34-1 | Cough & Cold Preparations |
19 | Pregabalin (USP/EP) | 148553-50-8 | Anti-Convulsant |
20 | Tigecycline (USP/EP) | 220620-09-7 | Anti-Biotic |
21 | Moxifloxacin HCl (IP/USP/EP) | 354812‐41‐2 | Anti-Bacterial |
22 | Tapentadol (in HOUSE SPEC) | 175591-23-8 | Anti-Analgesic |
23 | Beta-carotene ( USP/EP/BP) | 7235-40-7 | Carotenoids |
APIs Under Development | |||
S.No | Name | CAS No | Therapeutic Area |
24 | Propofol (USP/EP) | 2078-54-8 | General Anesthesia |
25 | Minocycline (USP/EP) | 10118-90-8 | Anti-Biotic |
26 | Linezolid IP (USP/EP) | 165800-03-3 | |
27 | Dronedarone (USP/EP/BP) | 141626-36-0 | Anti-Arrythmics |
28 | Citicoline Sodium (CP) | 987-78-0 | Brain Injuries |
29 | Pentosan Polysulfate(Sodium Salt) (IN HOUSE) | 116001-96-8 | Interstitial Cystitis |
Pellets Offered | |||
S.No | Name | CAS No | Therapeutic Area |
30 | Omeprazole Pellets(7.5%,8.5% & 10%) | Anti Ulceratives | |
31 | Lansoprazole Pellets(7.5%,8.5%,10% & 11.2%) | ||
32 | Esomeprazole Magnesium Pellets(8.5% & 22%) | ||
33 | Itraconazole Pellets(8.5% & 22%) | Anti Fungal | |
34 | Tamsulosin HCl Control Release Pellets(0.1%,0.2% & 0.4%) | Anti-Benign Prostatic Hyperplasia | |
Note: The products that are covered by valid patents will not be supplied by us to the respective countries.It is the responsibility of the importers to check for patents in their respective countries.We are not liable for any further repercussions arising out of the same. |